http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102924499-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53b4d53983adbf56dd0e7d0bf96f8ce5
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18
filingDate 2012-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb99f61ad695adfd52f21c985f2a4c48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c78c11cd12504cdf1e9c084720f6f1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd3c987381a57b9c623125d8742da773
publicationDate 2013-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102924499-A
titleOfInvention Synthesis of L-3,4,5-trioxo-phenylalanine/aldehyde compound
abstract The synthesis of L-3,4,5-trioxo-phenylalanine/aldehyde compound of the present invention provides L-3,4,5-trioxo-phenylalaninol (structural formula) of amino group and phenolic hydroxyl protection as follows) and efficiently convert it into protected L-3,4,5-trioxo-phenylalanine/aldehyde, and develop the synthesis of L-3,4,5-trioxo-benzene A concise and practical new method for alanine/aldehyde compounds. The L-3,4,5-trioxo-phenylalanine structure widely exists in many molecules with significant biological activities and functions, while L-3,4,5-trioxo-phenylalanine/aldehyde The compound is a very important intermediate for the chiral synthesis of tetrahydroisoquinoline alkaloids such as Ecteinascidin743, Phthalascidin650 and Saframycin with high anticancer activity. This method overcomes some deficiencies in previous synthesis, and has the advantages of short steps, high yield, cheap raw materials, easy operation, and easy industrialization, etc. A great way to compound.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106588698-A
priorityDate 2012-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102558250-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1471068-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7777073-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466407883
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468039555
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466262673
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468051248
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466639064

Total number of triples: 21.